These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33206290)

  • 21. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing use of elective mastectomy and contralateral prophylactic surgery among breast conservation candidates: a 14-year report from a comprehensive cancer center.
    Dragun AE; Pan J; Riley EC; Kruse B; Wilson MR; Rai S; Jain D
    Am J Clin Oncol; 2013 Aug; 36(4):375-80. PubMed ID: 22643566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
    Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
    J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.
    Kantor O; Ajmani G; Wang CH; Datta A; Yao K
    Ann Surg Oncol; 2018 Jan; 25(1):164-172. PubMed ID: 29127538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical Management of the Axilla in Patients with Occult Breast Cancer (cT0 N+) After Neoadjuvant Chemotherapy.
    Cohen BL; Collier AL; Kelly KN; Goel N; Kesmodel SB; Yakoub D; Moller M; Avisar E; Franceschi D; Macedo FI
    Ann Surg Oncol; 2020 Jun; 27(6):1830-1841. PubMed ID: 31989360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time to Curative-Intent Surgery in Gastric Cancer Shows a Bimodal Relationship with Overall Survival.
    Kaslow SR; He Y; Sacks GD; Berman RS; Lee AY; Correa-Gallego C
    J Gastrointest Surg; 2023 May; 27(5):855-865. PubMed ID: 36650415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort Study.
    Kim HJ; Dominici L; Rosenberg SM; Zheng Y; Pak LM; Poorvu PD; Ruddy KJ; Tamimi R; Schapira L; Come SE; Peppercorn J; Borges VF; Warner E; Vardeh H; Collins LC; Gaither R; King TA; Partridge AH
    Ann Surg; 2022 Jul; 276(1):173-179. PubMed ID: 33378304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant Chemotherapy for Breast Cancer, Is Practice Changing? A Population-Based Review of Current Surgical Trends.
    Graham PJ; Brar MS; Foster T; McCall M; Bouchard-Fortier A; Temple W; Quan ML
    Ann Surg Oncol; 2015 Oct; 22(10):3376-82. PubMed ID: 26202561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma.
    Hills N; Leslie M; Davis R; Crowell M; Kameyama H; Rui H; Chervoneva I; Dooley W; Tanaka T
    Ann Surg Oncol; 2021 Oct; 28(11):5895-5905. PubMed ID: 33748899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.
    Caudle AS; Yu TK; Tucker SL; Bedrosian I; Litton JK; Gonzalez-Angulo AM; Hoffman K; Meric-Bernstam F; Hunt KK; Buchholz TA; Mittendorf EA
    Breast Cancer Res; 2012 May; 14(3):R83. PubMed ID: 22621334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
    Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
    Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal Increases in Time to Surgery for Patients with Breast Cancer: A National Cohort Study.
    Tortorello GN; Shafique N; Keele L; Susman CG; Dheer A; Fayanju OM; Tchou J; Miura JT; Karakousis GC
    Ann Surg Oncol; 2024 Oct; 31(10):6804-6811. PubMed ID: 39003381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance).
    Golshan M; Cirrincione CT; Sikov WM; Berry DA; Jasinski S; Weisberg TF; Somlo G; Hudis C; Winer E; Ollila DW;
    Ann Surg; 2015 Sep; 262(3):434-9; discussion 438-9. PubMed ID: 26222764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society.
    Park S; Jeong J; Han W; Lee YJ; Kim HA; Lee S; Do Byun K; Choi YJ; Kim J; Bae SY
    Breast Cancer; 2021 Jul; 28(4):874-883. PubMed ID: 33586091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision making.
    Debled M; Auxepaules G; de Lara CT; Garbay D; Brouste V; Bussières E; Mauriac L; MacGrogan G
    Am J Surg; 2014 Nov; 208(5):756-763. PubMed ID: 24814311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical timing following neoadjuvant chemotherapy for breast cancer affects postoperative complication rates.
    Sutton TL; Johnson N; Schlitt A; Gardiner SK; Garreau JR
    Am J Surg; 2020 May; 219(5):741-745. PubMed ID: 32200974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience.
    Boér K; Kahán Z; Landherr L; Csőszi T; Máhr K; Ruzsa Á; Horváth Z; Budai B; Rubovszky G
    Pathol Oncol Res; 2021; 27():1609785. PubMed ID: 34257621
    [No Abstract]   [Full Text] [Related]  

  • 39. A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy.
    Matsuda N; Hayashi N; Ohde S; Yagata H; Kajiura Y; Yoshida A; Suzuki K; Nakamura S; Tsunoda H; Yamauchi H
    J Surg Oncol; 2014 Jun; 109(8):764-9. PubMed ID: 24647874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival After Primary Debulking Surgery Compared With Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A National Cancer Database Study.
    Seagle BL; Graves S; Strohl AE; Shahabi S
    Int J Gynecol Cancer; 2017 Oct; 27(8):1610-1618. PubMed ID: 28763362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.